NCT04833530

Brief Summary

Pulmonary aspiration is one of the most serious risks of general anesthesia and has been reported to occur in as many as 1 in 4000 cases of general anesthesia. Gastric ultrasound is an emerging point-of-care tool that provides bedside information on gastric content and volume. There have been a few factors which are thought to increase gastric size. Delayed gastric emptying such as caused by gastroparesis in Diabetes Mellitus is an example. Certain surgeries also cause gastroparesis. Other preoperative factors including pain, preoperative anxiety, and blood levels of estradiol or progesterone are less well studied.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 20, 2021

Completed
12 days until next milestone

Study Start

First participant enrolled

April 1, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 6, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

April 6, 2021

Status Verified

March 1, 2021

Enrollment Period

1 year

First QC Date

March 20, 2021

Last Update Submit

April 4, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Preoperative gastric ultrasound measurement

    Within 24 hours before Oocyte pickup

  • Post-anesthesia gastric ultrasound measurement

    During Oocyte pickup 1 hour

Study Arms (1)

Woman undergoing an gastric ultrasound assessment.

Woman undergoing general anesthesia for oocyte retrieval during in vitro fertilization, will undergo an gastric ultrasound assessment.

Diagnostic Test: Gastric Ultrasound

Interventions

Gastric UltrasoundDIAGNOSTIC_TEST

In the operating room, a gastric ultrasound will be performed in the supine position and the antral cross sectional area will be measured. Anesthesia will be induced in standard procedure and positive pressure will be instituted according to the standard protocol accepted in our hospital. At the end of the procedure, the gastric ultrasound circumference will be measured again.

Woman undergoing an gastric ultrasound assessment.

Eligibility Criteria

Age18 Years - 120 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWoman aged 18 and above undergoing general anesthesia for oocyte retrieval during in vitro fertilization with the ability to sign an informed consent.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Woman aged 18 and above undergoing general anesthesia for oocyte retrieval during in vitro fertilization with the ability to sign an informed consent.

You may qualify if:

  • Woman aged 18 and above undergoing general anesthesia for oocyte retrieval during in vitro fertilization with the ability to sign an informed consent.

You may not qualify if:

  • Women with BMI \>40
  • Women with diabetes
  • Women who have previously undergone gastric surgery
  • Women with language barriers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beilinson hospital

Petach Tikvah, Israel

Location

Related Publications (1)

  • Azem K, Orbach-Zinger S, Heesen P, Finkelstein A, Eidelman LA, Shufaro Y, Arzola C. The effect of preoperative anxiety and ovarian stimulation on gastric antrum size: a prospective observational study. J Psychosom Obstet Gynaecol. 2023 Dec;44(1):2170226. doi: 10.1080/0167482X.2023.2170226.

Study Officials

  • Sharon Orbach-zinger

    Rabin Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 20, 2021

First Posted

April 6, 2021

Study Start

April 1, 2021

Primary Completion

April 1, 2022

Study Completion

December 1, 2022

Last Updated

April 6, 2021

Record last verified: 2021-03

Locations